page contents
  • Anne

June 2020 News Update

Updated: Jun 29

In June 2020, the FDA approved an injectable combination of Herceptin (Trastuzumab) and Perjeta (Pertuzumab) which can be given instead of an infusion. This combination, called Phesgo, can be administered by a health professional at the patient's home, which is a considerable advantage for the patient.


©2019 Anne Loeser  The Insider's Guide to Metastatic Breast Cancer  All rights reserved